We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens
- Authors
Dai, Ming Shen; Feng, Yin Hsun; Chen, Shang Wen; Masuda, Norikazu; Yau, Thomas; Chen, Shou Tung; Lu, Yen Shen; Yap, Yoon Sim; Ang, Peter C. S.; Chu, Sung Chao; Kwong, Ava; Lee, Keun Seok; Ow, Samuel; Kim, Sung Bae; Lin, Johnson; Chung, Hyun Cheol; Ngan, Roger; Kok, Victor C.; Rau, Kun Ming; Sangai, Takafumi
- Publication
Breast Cancer Research & Treatment, 2021, Vol 189, Issue 3, p665
- ISSN
0167-6806
- Publication type
Article
- DOI
10.1007/s10549-021-06313-5